Nonattenuated Polymyxin B Used for the Treatment of Extreme-Drug Resistant Acinetobacter baumannii-Related Infections in Patients with Preexisting End Stage Renal Failure

Recent pharmacokinetic studies have suggested that nonrenal clearance predominates the elimination of polymyxin B. We present 2 patients with preexisting end stage renal failure, who were given nonattenuated doses of polymyxin B for the treatment of extreme-drug resistant organism. No evidence of ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yvonne Peijun, Chua, Nathalie Grace Sy, Chlebicki, Maciej Piotr, Lee, Winnie Hui Ling, Kwa, Andrea Lay Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065743/
https://www.ncbi.nlm.nih.gov/pubmed/24995135
http://dx.doi.org/10.1155/2014/573279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065743/
https://www.ncbi.nlm.nih.gov/pubmed/24995135
http://dx.doi.org/10.1155/2014/573279

Ejemplares similares